Welcome
The yet2.com global technology marketplace lists intellectual property, technology, and patents for technology transfer, technology licensing, patent licensing and patent sale. As premier technology brokers, yet2.com offers this essential IP marketplace for technology owners, technology seekers, and technology brokers interested in technology acquisition, patent licensing, intellectual property licensing (IP licensing), and intellectual property transfer.   more...

 Interested?
This is an abstract of a technology that is available for sale or license. yet2.com can introduce you confidentially to the owner of this technology.
To view the complete TechPak, please register with us.

 Still looking?
Enter a keyword or phrase below, and search now to find other technologies of interest.
 
 TechPak Categories
Novel Vanadium Complexes of Monohydroxamates for The Treatment of Type II Diabetes
The present invention relates to vanadium complexes useful for the treatment of diabetes. In vitro, vanadium salts mimic most of the effects of insulin on the main target tissues of the hormone. Initial clinical studies with low doses of vanadium have yielded several beneficial effects such as abolishing hyperglycemia. The potential usage of vanadium in the future care of diabetes in human, however, requires the development of forms of vanadium with increased insulinomimetic efficacy, without increasing its toxicity. The present invention shows that certain amino acid monohydroxamates interact with intracellular vanadium and and converts it into an active insulinomimetic species. This protocol is both more effective and less toxic than adminstering vanadium and therefore has the potential to be used to treat diabetes in humans in the future.Intensive studies carried last two decades insulinomimetic effects vanadium vitro salts mimic main target tissues hormone vivo induce normoglycemia andimprove glucose homeostasis insulin-deficient insulin-resistant diabetic rodents

Interested? This is an abstract of a technology that is available for sale or license. yet2.com can introduce you confidentially to the owner of this technology.
To view the complete TechPak, please register with us.
yet2.com TechPakTM produced by yet2.com. For an introduction to the owner of this technology please visit www.yet2.com or call:
Boston, MA, USA
+1 (781) 972-0600
fax +1 (781) 972-0601
Liverpool, United Kingdom
+44 (0) 151 705 3539
fax +44 (0) 151 705 3542
Tokyo, Japan
+81-3-5217-0217
fax +81-3-5217-0218
Copyright © 1999-2008 by yet2.com, Inc. All Rights Reserved.